News
Clinical Trial Services and the Role of a European CRO
Conducting a clinical trial today requires coordinated procedures, standardized documentation, and a clear understanding of the regulatory systems that govern research. As more studies extend across borders, the need for organizations with regional expertise becomes increasingly important. A European...
Business & Industry
AstraZeneca, Biopharma Giant, Announces $2bn Investment in Maryland
It should not be termed as an overstatement when we say that Maryland is fast becoming the home away from home when it comes to AstraZeneca, the British drugmaker. On November 21, the biopharma powerhouse pushed it up a...
BioPharma
FDA Looks to Accelerate Biosimilar Drug Development
The FDA has gone on to propose certain new policies in order to accelerate biosimilar drug development and at the same time also lower the cost pertaining to biosimilar agents when it comes to cancer as well as any...
News
Onshoring of Drug Product Manufacturing to Massachusetts
Moderna is set to expand its US manufacturing capabilities through the onshoring of drug product manufacturing to its present Moderna Technology Center - MTC located Norwood, Massachusetts, in a move that involves an investment of over $140m.
By way of this onshoring,...
BioPharma
Australian Biopharma to Expand US Plasma-Derived Therapies
The Australian-based biopharma company, CSL, plans to invest almost $1.5 billion in the next five years so as to expand its presence in the U.S. However, this is going to be subject to the approval from the board of...
Business & Industry
Pfizer to Acquire Metsera in a $10bn Deal as Board Backs
The news of Pfizer to acquire Metsera in a $10bn deal has indeed caught the eye of many. Metsera happens to be a US-based biotechnology firm and the deal was indeed a result of a heated bidding battle against...
BioPharma
Sofinnova Partners Raises $750mn to Support Biotech Startups
European venture capital firm Sofinnova Partners said on November 17 that it raised 650 million euros, equivalent to $750 million, for a new fund that is going to support the present and upcoming life sciences companies.
It is well to be...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read